Literature DB >> 21966319

Regional differences in acute stroke admission and thrombolysis rates in the German federal state of Hesse.

Erwin Stolz1, Gerhard F Hamann, Manfred Kaps, Björn Misselwitz.   

Abstract

BACKGROUND: Using data from the mandatory quality assurance program for stroke care in Hesse, we analyze regional differences in thrombolysis rates and infer some ways in which care can be improved.
METHODS: We identified 7707 patients with acute ischemic stroke who were admitted to hospital within 3 hours of symptom onset in 2007 and 2008, and we determined the local thrombolysis rate district by district. In order to exclude the possibility that the observed local differences in thrombolysis rates might be accounted for, in large part, by off-label thrombolysis procedures, we further narrowed down the subgroup of patients who underwent thrombolysis to the 1108 patients admitted within 2 hours of symptom onset. We also analyzed the local thrombolysis rates for patients who were primarily referred to stroke units.
RESULTS: The overall thrombolysis rate among patients admitted within 3 hours of symptom onset was 19%, varying locally from 6% to 35%. Among patients admitted within 2 hours of symptom onset, the local thrombolysis rate ranged from 13% to 85%. Even in patients primarily referred to stroke units, the local thrombolysis rate ranged from 8% to 44% in the 3-hour group and from 16% to 62% in the 2-hour group.
CONCLUSION: Local thrombolysis rates vary unexpectedly widely across the state of Hesse. The care of patients with acute stroke after they reach the hospital urgently needs critical reappraisal and improvement.

Entities:  

Mesh:

Year:  2011        PMID: 21966319      PMCID: PMC3183304          DOI: 10.3238/arztebl.2011.0607

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  3 in total

1.  Development and implementation of evidence-based indicators for measuring quality of acute stroke care: the Quality Indicator Board of the German Stroke Registers Study Group (ADSR).

Authors:  Peter U Heuschmann; Marcel K Biegler; Otto Busse; Susanne Elsner; Armin Grau; Uwe Hasenbein; Peter Hermanek; Rudolf W C Janzen; Peter L Kolominsky-Rabas; Peter L Kolominisky-Rabas; Klaus Kraywinkel; Klaus Lowitzsch; Bjoern Misselwitz; Darius G Nabavi; Kirsten Otten; Ludger Pientka; Gerhard M von Reutern; Erich Bernd Ringelstein; Dirk Sander; Markus Wagner; Klaus Berger
Journal:  Stroke       Date:  2006-09-07       Impact factor: 7.914

2.  Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study.

Authors:  Maaike Dirks; Louis W Niessen; Peter J Koudstaal; Cees L Franke; Robert J van Oostenbrugge; Diederik W J Dippel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-01       Impact factor: 10.154

3.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

  3 in total
  13 in total

1.  Local versus specialized treatment: the difficulty in interpreting regional variations in treatment.

Authors:  Klaus Berger
Journal:  Dtsch Arztebl Int       Date:  2011-09-09       Impact factor: 5.594

2.  [Reality of acute stroke patient care in the metropolitan Ruhr area: status quo and perspectives of a stroke-specific network].

Authors:  J Eyding; M Kitzrow; D Bartig; H-U Sorgenfrei; C Krogias
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

3.  The quality of acute stroke care- an analysis of evidence-based indicators in 260 000 patients.

Authors:  Silke Wiedmann; Peter U Heuschmann; Steffi Hillmann; Otto Busse; Horst Wiethölter; Georg M Walter; Günter Seidel; Björn Misselwitz; Alfred Janssen; Klaus Berger; Christoph Burmeister; Christine Matthis; Peter Kolominsky-Rabas; Peter Hermaneks
Journal:  Dtsch Arztebl Int       Date:  2014-11-07       Impact factor: 5.594

4.  Does treatment with t-PA increase the risk of developing epilepsy after stroke?

Authors:  Lena Keller; Carsten Hobohm; Samira Zeynalova; Joseph Classen; Petra Baum
Journal:  J Neurol       Date:  2015-07-24       Impact factor: 4.849

5.  Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice.

Authors:  Christian Tanislav; Sonja Milde; Sabine Schwartzkopff; Björn Misselwitz; Nicole Sieweke; Manfred Kaps
Journal:  BMC Res Notes       Date:  2015-06-25

6.  Lessons from everyday stroke care for clinical research and vice versa: comparison of a comprehensive and a research population of young stroke patients.

Authors:  Christian Tanislav; Ulrike Grittner; Bjoern Misselwitz; Gerhard Jan Jungehuelsing; Christian Enzinger; Bettina von Sarnowski; Jukka Putaala; Manfred Kaps; Peter Kropp; Arndt Rolfs; Turgut Tatlisumak; Franz Fazekas; Edwin Kolodny; Bo Norrving
Journal:  BMC Neurol       Date:  2014-03-07       Impact factor: 2.474

7.  Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice.

Authors:  Christian Tanislav; Sonja Milde; Sabine Schwartzkopff; Nicole Sieweke; Heidrun Helga Krämer; Martin Juenemann; Björn Misselwitz; Manfred Kaps
Journal:  BMC Neurol       Date:  2014-09-30       Impact factor: 2.474

8.  Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better?

Authors:  S Scherf; M Limburg; R Wimmers; I Middelkoop; H Lingsma
Journal:  BMC Neurol       Date:  2016-04-21       Impact factor: 2.474

9.  Expansion or compression of long-term care in Germany between 2001 and 2009? A small-area decomposition study based on administrative health data.

Authors:  Daniel Kreft; Gabriele Doblhammer
Journal:  Popul Health Metr       Date:  2016-07-13

Review 10.  Recent advances in the management of acute ischemic stroke.

Authors:  Philip Chang; Shyam Prabhakaran
Journal:  F1000Res       Date:  2017-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.